GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,645,000 | +0.8% | 83,768 | +0.8% | 0.02% | +16.7% |
| Q1 2022 | $3,617,000 | -4.1% | 83,063 | -2.9% | 0.02% | 0.0% |
| Q4 2021 | $3,771,000 | +1.5% | 85,546 | -12.1% | 0.02% | -5.3% |
| Q3 2021 | $3,717,000 | -5.0% | 97,327 | -0.9% | 0.02% | -5.0% |
| Q2 2021 | $3,911,000 | +2.9% | 98,243 | -7.7% | 0.02% | 0.0% |
| Q1 2021 | $3,799,000 | +2.4% | 106,471 | +5.6% | 0.02% | 0.0% |
| Q4 2020 | $3,709,000 | -30.2% | 100,794 | -28.6% | 0.02% | -37.5% |
| Q3 2020 | $5,314,000 | -15.3% | 141,229 | -8.2% | 0.03% | -15.8% |
| Q2 2020 | $6,273,000 | -42.3% | 153,811 | -33.5% | 0.04% | -24.0% |
| Q1 2020 | $10,874,000 | 0.0% | 231,438 | 0.0% | 0.05% | 0.0% |
| Q4 2019 | $10,874,000 | +7.1% | 231,438 | -2.7% | 0.05% | +8.7% |
| Q3 2019 | $10,155,000 | +7.1% | 237,970 | +0.4% | 0.05% | +9.5% |
| Q2 2019 | $9,479,000 | -4.9% | 236,919 | -0.7% | 0.04% | -6.7% |
| Q1 2019 | $9,969,000 | +32.5% | 238,583 | +21.1% | 0.04% | +21.6% |
| Q4 2018 | $7,523,000 | +51.3% | 196,932 | +59.1% | 0.04% | +85.0% |
| Q3 2018 | $4,972,000 | -10.6% | 123,797 | -10.2% | 0.02% | -20.0% |
| Q2 2018 | $5,559,000 | +10.8% | 137,903 | -2.5% | 0.02% | +19.0% |
| Q1 2018 | $5,016,000 | 0.0% | 141,443 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $5,016,000 | -13.0% | 141,443 | -0.4% | 0.02% | -16.0% |
| Q3 2017 | $5,766,000 | -56.8% | 142,053 | -55.1% | 0.02% | -60.9% |
| Q2 2017 | $13,336,000 | 0.0% | 316,352 | 0.0% | 0.06% | 0.0% |
| Q1 2017 | $13,336,000 | +4.8% | 316,352 | -4.3% | 0.06% | -7.2% |
| Q4 2016 | $12,730,000 | -11.2% | 330,592 | -0.6% | 0.07% | -14.8% |
| Q3 2016 | $14,339,000 | +2.3% | 332,489 | +2.8% | 0.08% | -4.7% |
| Q2 2016 | $14,023,000 | +16.4% | 323,583 | +8.9% | 0.08% | +9.0% |
| Q1 2016 | $12,043,000 | +98.3% | 297,019 | +97.3% | 0.08% | +90.2% |
| Q4 2015 | $6,073,000 | +6.6% | 150,550 | +1.6% | 0.04% | -2.4% |
| Q3 2015 | $5,696,000 | -7.7% | 148,188 | +0.0% | 0.04% | -6.7% |
| Q2 2015 | $6,169,000 | -24.0% | 148,152 | -15.8% | 0.04% | -23.7% |
| Q1 2015 | $8,114,000 | +3.3% | 175,857 | -4.3% | 0.06% | -4.8% |
| Q4 2014 | $7,855,000 | +5.2% | 183,826 | +13.2% | 0.06% | -4.6% |
| Q3 2014 | $7,466,000 | -19.2% | 162,442 | -5.9% | 0.06% | -21.7% |
| Q2 2014 | $9,235,000 | -6.8% | 172,702 | -6.9% | 0.08% | -9.8% |
| Q1 2014 | $9,913,000 | -1.9% | 185,555 | -1.9% | 0.09% | -10.7% |
| Q4 2013 | $10,101,000 | +7.9% | 189,209 | +1.4% | 0.10% | -7.2% |
| Q3 2013 | $9,359,000 | -1.7% | 186,579 | -2.1% | 0.11% | -6.7% |
| Q2 2013 | $9,521,000 | – | 190,557 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |